|
Oct 5
|
Novartis AG (NVS): Driving Long-Term Growth with Strong Pipeline and Innovative Products
|
|
Oct 2
|
Here's Why You Should Add ALNY Stock to Your Portfolio Right Now
|
|
Oct 1
|
US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next
|
|
Sep 30
|
Top Research Reports for Apple, Tesla & T-Mobile US
|
|
Sep 30
|
Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
|
|
Sep 27
|
Volkswagen, Novartis could surprise in Q3 earnings season, UBS analysts warn
|
|
Sep 25
|
Generate:Biomedicines and Novartis link on protein therapeutics development
|
|
Sep 24
|
Metsera touts long-acting GLP-1 drug; Novartis strikes an AI deal
|
|
Aug 29
|
Novartis teams up with Lindy Biosciences to improve biologic delivery
|
|
Aug 29
|
Novartis' Cholesterol Drug Meets Primary Goals in Late-Stage Study
|
|
Aug 29
|
Novartis’ Phase III trial of Leqvio in ASCVD patients meets primary endpoints
|
|
Aug 28
|
Novartis AG (NVS): A Cheap Pharmaceutical Stock to Buy According to Short Sellers
|
|
Aug 28
|
Novartis' Cholesterol-Lowering Drug Shows Encouraging Outcome In Late-Stage Study
|
|
Aug 28
|
Lindy Biosciences Enters Licensing and Collaboration Agreement With Novartis for Multi-target Drug Delivery Innovation
|
|
Aug 28
|
Five alternatives to Mag 7 stocks if you missed out on Nvidia
|
|
Aug 28
|
Novartis twice-yearly* Leqvio® demonstrated clinically meaningful, statistically significant LDL-C lowering as a monotherapy in patients at low or moderate ASCVD risk
|
|
Aug 27
|
Siemens Healthineers to grow PET imaging with purchase of Novartis assets
|
|
Aug 26
|
Why This Rival To Gilead, Novartis Just Jumped 10% — And Why There Are Caveats
|
|
Aug 26
|
European Equities Close Mixed in Monday Trading; EU Trade Balance Records Surplus for 4th Straight Quarter
|
|
Aug 26
|
Siemens Healthineers to acquire Novartis’ diagnostics arm
|